Deepa Bedi

434 total citations
15 papers, 167 citations indexed

About

Deepa Bedi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Deepa Bedi has authored 15 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Deepa Bedi's work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Adipose Tissue and Metabolism (3 papers). Deepa Bedi is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Adipose Tissue and Metabolism (3 papers). Deepa Bedi collaborates with scholars based in United States, Bangladesh and Taiwan. Deepa Bedi's co-authors include Valery A. Petrenko, James W. Gillespie, Brandon L. Brunson, Qiao Zhong, Robert L. Judd, Prashanth K. Jayanna, R. Curtis Bird, Patricia DeInnocentes, John C. Dennis and Tao Wang and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Deepa Bedi

13 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deepa Bedi United States	7	81	43	34	32	30	15	167
Lindsey Chudley United Kingdom	7	94 1.2×	12 0.3×	69 2.0×	23 0.7×	4 0.1×	10	211
Jun Yeop Lee South Korea	4	161 2.0×	14 0.3×	63 1.9×	32 1.0×	2 0.1×	7	262
Fazhi Yu China	8	57 0.7×	5 0.1×	25 0.7×	30 0.9×	7 0.2×	13	192
S.E. Combs United States	6	70 0.9×	9 0.2×	131 3.9×	12 0.4×	7 0.2×	10	235
Cornelius Schneider Germany	10	265 3.3×	5 0.1×	42 1.2×	5 0.2×	29 1.0×	14	313
Huaming Sun United States	6	134 1.7×	6 0.1×	14 0.4×	6 0.2×	10 0.3×	8	236
Kimberly Cramer Germany	7	92 1.1×	13 0.3×	15 0.4×	6 0.2×	9 0.3×	8	177
Y. Morizane Japan	7	161 2.0×	8 0.2×	30 0.9×	13 0.4×	2 0.1×	9	229
Kareen Bartsch Germany	4	145 1.8×	9 0.2×	40 1.2×	20 0.6×	2 0.1×	4	231
Sandra Kissing Germany	5	67 0.8×	5 0.1×	8 0.2×	37 1.2×	8 0.3×	5	191

Countries citing papers authored by Deepa Bedi

Since Specialization

Citations

This map shows the geographic impact of Deepa Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa Bedi more than expected).

Fields of papers citing papers by Deepa Bedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa Bedi. The network helps show where Deepa Bedi may publish in the future.

Co-authorship network of co-authors of Deepa Bedi

This figure shows the co-authorship network connecting the top 25 collaborators of Deepa Bedi. A scholar is included among the top collaborators of Deepa Bedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepa Bedi. Deepa Bedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Bedi, Deepa, et al.. (2025). The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides. Molecular & Cellular Oncology. 12(1). 2471640–2471640. 1 indexed citations

Jenkins, Brittany D., Sandeep K. Singhal, Kevin Gardner, et al.. (2023). Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 Signaling. Cancers. 15(8). 2282–2282. 3 indexed citations

Samuel, Temesgen, et al.. (2023). Abstract 1238: Loss of HSPD1 induces cellular plasticity in triple-negative breast cancer cells. Cancer Research. 83(7_Supplement). 1238–1238.

Bedi, Deepa, et al.. (2023). Abstract C111: Spatial transcriptome profiling of tumor and tumor microenvironment of triple negative breast cancer in patients of African American and European American descent. Cancer Epidemiology Biomarkers & Prevention. 32(1_Supplement). C111–C111. 1 indexed citations

Bedi, Deepa, Payal Agarwal, Amol Suryawanshi, et al.. (2022). Development of OX40 agonists for canine cancer immunotherapy. iScience. 25(10). 105158–105158. 7 indexed citations

Angajala, Anusha, Aliyu Muhammad, Honghe Wang, et al.. (2022). MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans. Scientific Reports. 12(1). 22178–22178. 4 indexed citations

Smith, B. F., et al.. (2022). Characterization of Canine Adenovirus Type 2 Virus Infection Pattern in Canine and Human Cell Lines. Advances in Virology. 2022. 1–10.

Jaiswal, Anil K., Robert J. Pantazes, Payal Agarwal, et al.. (2021). Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients. Scientific Reports. 11(1). 20763–20763. 14 indexed citations

Angajala, Anusha, Melissa B. Davis, Shweta Tripathi, et al.. (2018). Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer. Translational Oncology. 12(3). 493–501. 23 indexed citations

10.

Bedi, Deepa, James W. Gillespie, & Valery A. Petrenko. (2014). Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. Protein Engineering Design and Selection. 27(7). 235–243. 24 indexed citations

11.

Jayanna, Prashanth K., Deepa Bedi, James W. Gillespie, et al.. (2010). Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency. Nanomedicine Nanotechnology Biology and Medicine. 6(4). 538–546. 33 indexed citations

12.

Horikawa, Shin, Suiqiong Li, Deepa Bedi, et al.. (2010). Effects of Surface Phage Coverage on the Performance of Wireless Phage-Immobilized Magnetoelastic Biosensors. ECS Transactions. 33(8). 41–48. 3 indexed citations

13.

Bedi, Deepa, et al.. (2008). Landscape Phage Probes for Breast Cancer Cells. TechConnect Briefs. 2(2008). 461–464. 3 indexed citations

14.

Brunson, Brandon L., Qiao Zhong, Deepa Bedi, et al.. (2007). Serum concentrations of adiponectin and characterization of adiponectin protein complexes in dogs. American Journal of Veterinary Research. 68(1). 57–62. 24 indexed citations

15.

Bedi, Deepa, John C. Dennis, Qiao Zhong, et al.. (2006). Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Biochemical and Biophysical Research Communications. 345(1). 332–339. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact